Sorafenib Metabolism Is Significantly Altered in the Liver Tumor Tissue of Hepatocellular Carcinoma Patient
2014 · PLoS ONE · 58 citations
https://doi.org/10.1371/journal.pone.0096664
E
Enshuang Guo
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
13
Papers
386
Citations
7
h-index
7
i10-index
Enshuang Guo is an academic researcher from First Affiliated Hospital of Zhengzhou University. The author has contributed to research in topics: Autophagy in Disease and Therapy & Liver Disease Diagnosis and Treatment & Pharmacogenetics and Drug Metabolism. The author has an h-index of 7, co-authored 12 publications.
ORCID: 0000-0002-1718-8156Papers by this author
worksFK866 attenuates acute hepatic failure through c-jun-N-terminal kinase (JNK)-dependent autophagy
2017 · Scientific Reports · 21 citations
https://doi.org/10.1038/s41598-017-02318-7
HOXB4/METTL7B cascade mediates malignant phenotypes of hepatocellular carcinoma through TKT m6A modification
2025 · Biology Direct · 2 citations
https://doi.org/10.1186/s13062-025-00620-3
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat